What is PharmaCenter?
PharmaCenter operates as a prominent provider of natural supplement products and services, leveraging almost 20 years of industry expertise. The company excels in custom manufacturing, producing a diverse range of dosage forms including gummies, softgels, capsules, and tablets. Furthermore, PharmaCenter offers comprehensive private labeling and contract packaging solutions, ensuring the efficient and high-quality delivery of client products. Their core clientele comprises businesses seeking premium supplement manufacturing and bespoke service solutions.
How much funding has PharmaCenter raised?
PharmaCenter has raised a total of $125K across 1 funding round:
Debt
$125K
Debt (2021): $125K with participation from PPP
Key Investors in PharmaCenter
PPP
Public-Private Partnership
What's next for PharmaCenter?
With its substantial late-stage funding, PharmaCenter is strategically positioned for accelerated growth and market expansion. The recent strategic investment is likely to fuel advancements in manufacturing capabilities, potentially broadening their product portfolio and enhancing their service offerings to meet increasing market demand. This capital infusion will enable PharmaCenter to solidify its leadership in the competitive natural supplement and contract manufacturing landscape, driving innovation and operational excellence.
See full PharmaCenter company page
